Hepatic clearance of Salmonella typhimurium in silica treated mice

Richard L Friedman, R. J. Moon

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Scanning electron microscopy demonstrates that crystalline silica destroys liver Kupffer cells but has no other obvious deleterious effects on the liver. Silica-treated livers still retain the ability to trap large numbers of bacteria perfused through the portal vein even though the rate of clearance is well below normal. In vivo, silica treatment decreases the rate of bacterial clearance from the blood, alters the in vivo organ distribution of cleared bacteria, and decreases the mean lethal dose of Salmonella typhimurium over 100-fold. Cumulatively, the data indicate that silica treatment enhances susceptibility to gram-negative infection, probably by destruction of macrophages.

Original languageEnglish (US)
Pages (from-to)1005-1012
Number of pages8
JournalInfection and Immunity
Volume16
Issue number3
StatePublished - 1977
Externally publishedYes

Fingerprint

Salmonella typhimurium
Silicon Dioxide
Liver
Bacteria
Kupffer Cells
Portal Vein
Electron Scanning Microscopy
Macrophages
Infection

ASJC Scopus subject areas

  • Immunology

Cite this

Hepatic clearance of Salmonella typhimurium in silica treated mice. / Friedman, Richard L; Moon, R. J.

In: Infection and Immunity, Vol. 16, No. 3, 1977, p. 1005-1012.

Research output: Contribution to journalArticle

@article{e019c7f5d9a24c80b00dd88f57628d88,
title = "Hepatic clearance of Salmonella typhimurium in silica treated mice",
abstract = "Scanning electron microscopy demonstrates that crystalline silica destroys liver Kupffer cells but has no other obvious deleterious effects on the liver. Silica-treated livers still retain the ability to trap large numbers of bacteria perfused through the portal vein even though the rate of clearance is well below normal. In vivo, silica treatment decreases the rate of bacterial clearance from the blood, alters the in vivo organ distribution of cleared bacteria, and decreases the mean lethal dose of Salmonella typhimurium over 100-fold. Cumulatively, the data indicate that silica treatment enhances susceptibility to gram-negative infection, probably by destruction of macrophages.",
author = "Friedman, {Richard L} and Moon, {R. J.}",
year = "1977",
language = "English (US)",
volume = "16",
pages = "1005--1012",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Hepatic clearance of Salmonella typhimurium in silica treated mice

AU - Friedman, Richard L

AU - Moon, R. J.

PY - 1977

Y1 - 1977

N2 - Scanning electron microscopy demonstrates that crystalline silica destroys liver Kupffer cells but has no other obvious deleterious effects on the liver. Silica-treated livers still retain the ability to trap large numbers of bacteria perfused through the portal vein even though the rate of clearance is well below normal. In vivo, silica treatment decreases the rate of bacterial clearance from the blood, alters the in vivo organ distribution of cleared bacteria, and decreases the mean lethal dose of Salmonella typhimurium over 100-fold. Cumulatively, the data indicate that silica treatment enhances susceptibility to gram-negative infection, probably by destruction of macrophages.

AB - Scanning electron microscopy demonstrates that crystalline silica destroys liver Kupffer cells but has no other obvious deleterious effects on the liver. Silica-treated livers still retain the ability to trap large numbers of bacteria perfused through the portal vein even though the rate of clearance is well below normal. In vivo, silica treatment decreases the rate of bacterial clearance from the blood, alters the in vivo organ distribution of cleared bacteria, and decreases the mean lethal dose of Salmonella typhimurium over 100-fold. Cumulatively, the data indicate that silica treatment enhances susceptibility to gram-negative infection, probably by destruction of macrophages.

UR - http://www.scopus.com/inward/record.url?scp=0017711293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017711293&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 1005

EP - 1012

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 3

ER -